Advertisement

Oral Signs of Tropical, Fungal, and Parasitic Diseases

  • Ricardo Pérez-Alfonzo
  • Silvio Alencar-Marques
  • Elda Giansante
  • Antonio Guzmán-Fawcett
Chapter

Abstract

More than 50% of the world population live in the tropics mostly in developing countries, with great poverty and poor essential goods, services, and access. These conditions and environmental factors make the population high risk for a group of fungal, bacterial, and parasitic diseases, many of which affect the oral mucosa.

Keywords

Oral pathology Tropical Fungal Parasitic Candidiasis Actinomycosis Histoplasmosis Mucormycosis Paracoccidioidomycosis Blastomycosis Aspergillosis Cryptococcus Coccidioidomycosis Leishmaniasis Yaws Endemic syphilis 

Notes

Acknowledgment

The authors would like to acknowledge the valuable suggestions made by Lic. María Eugenia Gallinoto (Instituto de Biomedicina “Dr. Jacinto Convit,” Universidad Central de Venezuela) and Dr. Jacobus H. de Waard (Microbiologist Tuberculosis Department, Instituto de Biomedicina “Dr. Jacinto Convit,” Universidad Central de Venezuela).

References

  1. 1.
    Arenas R, Estrada R. Tropical dermatology, Vademècum. Georgetown: Landes Biosciences; 2001. ISBN1-57059-493-7.Google Scholar
  2. 2.
    Bonifaz A. Micología Médica Básica cuarta Edición. New York: McGraw Hill; 2012.Google Scholar
  3. 3.
    Martins N, Ferreira IC, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, preventions, diagnosis and alternative treatment. Mycopathologia. 2014;177:223–40.PubMedGoogle Scholar
  4. 4.
    Bork K, Hoede N, Korting G, Burgdorf W, Young S. Diseases of the oral mucosa and the lips. 2nd ed. Philadelphia: WB Saunders; 1996.Google Scholar
  5. 5.
    Sakaguchi H. Treatment and prevention of oral candidiasis in elderly patients. Med Mycol J. 2017;58:J43–9.PubMedGoogle Scholar
  6. 6.
    Hani U, Shivakumar HG, Vaghela R, Osmani RAM, Shrivastava A. Candidiasis: a fungal infection- current challenges and progress in prevention and treatment. Infect Disord – Drug Targets. 2015;15:42–52.PubMedGoogle Scholar
  7. 7.
    Moghimi M, Salentijn E, Debets-Ossenkop Y, Karagozoglu KH, Forounzanfar T. Treatment of cervicofacial actinomycosis: a report of 19 cases and review of literature. Med Oral Patol Oral Cir Bucal. 2013;18:e627–32.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Kolm I, Aceto L, Hombach M, Kamarshev J, Hafner J, Urosevic-Maiwald M. Cervicofacial actinomycosis: a long forgotten infectious complication of immunosuppression – report of a case and review of the literature. Dermatol Online J. 2014;20:22640.PubMedGoogle Scholar
  9. 9.
    Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Fadda GL, Gisolo M, Crosetti E, Fulcheri A, Succo G. Intracranial complication of rhinosinusitis from actinomycosis of the paranasal sinuses: a rare case of abducens nerve palsy. Case Rep Otolaryngol. 2014;2014:601671.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Cohen PR, Tschen JA. Tonsillar actinomycosis mimicking a tonsillolith: colonization of the palantine tonsil presenting as a foul-smelling, removable, unilateral, giant tonsillar concretion. Int J Dermatol. 2010;49:1165–8.PubMedGoogle Scholar
  12. 12.
    Eidbo J, Sanchez RL, Tschen JA, Ellner KM. Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome. Am J Surg Pathol. 1993;17:110–6.PubMedGoogle Scholar
  13. 13.
    Marques SA, Silvares MR, Camargo RM, Marques ME. Cutaneous histoplasmosis disclosing an HIV-infection. An Bras Dermatol. 2013;88:420–3.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Corti M, Villafañe MF, Palmieri O, Negroni R. Rupioid histoplasmosis: first case reported in an AIDS patient in Argentina. Rev Inst Med Trop Sao Paulo. 2010;52:279–80.PubMedGoogle Scholar
  15. 15.
    Ollague Sierra JEI, Ollague Torres JM. New clinical and histological pattern of acute disseminated histoplasmosis in human immunodeficiency virus positive patients with acquired immunodeficiency syndrome. Am J Dermatophatol. 2013;35:203–12.Google Scholar
  16. 16.
    Ge L, Zhou C, Song Z, Zhang Y, Wang L, Zhong B, Hao F. Primary localized histoplasmosis with lesions restricted to the mouth in a Chinese HIV negative patient. Int J Infect Dis. 2010;14(Suppl 3):e325–8.PubMedGoogle Scholar
  17. 17.
    Iqbal FL, Schifter M, Coleman HG. Oral presentation of histoplasmosis in an immunocompetent patient: a diagnostic challenge. Aust Dent J. 2014;59:386–8.PubMedGoogle Scholar
  18. 18.
    Wheat J, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA, Infectious Diseases Society of America. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807–25.PubMedGoogle Scholar
  19. 19.
    Restrepo A, Tobon A, Clark B, Graham DR, Corcoran G, Bradsher RW, et al. Salvage treatment of histoplasmosis with posaconazole. J Inf Secur. 2007;54:319–27.Google Scholar
  20. 20.
    Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48:1743–51.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Marques SA. Fungal infections of the mucous membrane. Dermatol Ther. 2010;23:244–51.Google Scholar
  22. 22.
    Bonifaz A, Macias B, Paredes-Farreira F, Arias P, Ponce RM, Araiza J. Palatal zygomycosis: experience of 21 cases. Oral Dis. 2008;14:569–74.PubMedGoogle Scholar
  23. 23.
    Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30:851–6.PubMedGoogle Scholar
  24. 24.
    Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909–17.PubMedGoogle Scholar
  25. 25.
    Bonifaz A, Vázquez-González D, Tirado-Sánchez A, Ponce-Olivera RM. Cutaneous zygomycosis. Clin Dermatol. 2012;30:413–9.PubMedGoogle Scholar
  26. 26.
    Bonifaz A, Tirado-Sánchez A, Calderón L, Romero-Cabello R, Kassack J, Ponce RM, et al. Mucormycosis in children: a study of 22 cases in a Mexican hospital. Mycoses. 2014;57(Suppl 3):79–84.PubMedGoogle Scholar
  27. 27.
    Ameen M, Arenas R, Martinez-Luna E, Reyes M, Zacarias R. The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology. Int J Dermatol. 2007;46:380–4.PubMedGoogle Scholar
  28. 28.
    Reed G, Ibrahim A, Edwards J Jr. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother. 2006;50:3968–9.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Bagagli E, Theodoro RC, Bosco SM, McEwen JG. Paracoccidioidesbrasiliensis: phylogenetic and ecological aspects. Mycopathologia. 2008;165:197–207.PubMedGoogle Scholar
  30. 30.
    Matute DR, McEwen JG, Puccia R, Montes BA, San-Blas G, Bagagli E, et al. Cryptic speciation and recombination in the fungus Paracoccidioidesbrasiliensis as revealed by gene genealogies. Mol Biol Evol. 2006;23:65–73.PubMedGoogle Scholar
  31. 31.
    Matute DR, Sepulveda VE, Quesada LM, Goldman GH, Taylor JW, Restrepo A, et al. Microsatellite analysis of three phylogenetic species of Paracoccidioidesbrasiliensis. J Clin Microbiol. 2006;44:2153–7.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Teixeira MM, Theodoro RC, de Carvalho MJ, Fernandes L, Paes HC, Hahn RC. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol Phylogenet Evol. 2009;52:273–83.PubMedGoogle Scholar
  33. 33.
    Theodoro RC, Teixeira Mde M, Felipe MS, Paduan Kdos S, Ribolla PM, San-Blas G, et al. Genus Paracoccidioides: species recognition and biogeographic aspects. PLoSOne. 2012;7:e37694.Google Scholar
  34. 34.
    Turissini DA, Gomez OM, Teixeira MM, McEwen JG, Matute DR. Species boundaries in the human pathogen Paracoccidioides. Fungal Genet Biol. 2017;106:9–25.PubMedGoogle Scholar
  35. 35.
    Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the Southeast of Brazil. Am J Trop Med Hyg. 2011;85:546–50.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Marques SA. Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating. An Bras Dermatol. 2013;88:700–11.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon N, Mota NGS. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop. 1987;20:129–32.PubMedGoogle Scholar
  38. 38.
    Marques SA, Cortez DB, Lastória JC, Camargo RMP, Marques MEA. Paracoccidioidomycosis: frequency, morphology and pathogenesis of tegumentary lesions. An Bras Dermatol. 2007;82:411–7.Google Scholar
  39. 39.
    Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasuda MA. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis. 2007;45:1462–9.PubMedGoogle Scholar
  40. 40.
    Peçanha PM, Souza S, Falqueto A, Grão-Veloso TR, Lírio LV, Ferreira CUG Jr, et al. Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series. Int J Antimicrob Agents. 2016;48:428–30.PubMedGoogle Scholar
  41. 41.
    Shikanai-Yasuda MA, TellesFilho FQ, Mendes RP, Colombo AL, Moretti ML. Grupo de Consultores do Consenso em Paracoccidiodomicose. Consenso em paracoccidioidomicose. Rev Soc Bras Med Trop. 2006;39:297–310.PubMedGoogle Scholar
  42. 42.
    Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev. 2010;23:367–81.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Rucci J, Eisinger G, Miranda-Gomez G, Nguyen J. Blastomycosis of the head and neck. Am J Otolaryngol. 2014;35:390–5.PubMedGoogle Scholar
  44. 44.
    Kruse AL, Zwahlen RA, Bredell MG, Gengler C, Dannemann C, Grätz KW. Primary blastomycosis of oral cavity. J Craniofac Surg. 2010;21:121–3.PubMedGoogle Scholar
  45. 45.
    Fanucci E, Nezzo M, Neroni L, Montesani L Jr, Ottria L, Gargari M. Diagnosis and treatment of paranasal sinus fungus ball of odontogenic origin: case report. Oral Implantol (Rome). 2014;6(3):63–6.Google Scholar
  46. 46.
    Grosjean P, Weber R. Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol. 2007;264:461–70.PubMedGoogle Scholar
  47. 47.
    Ganesh P, Nagarjuna M, Shetty S, Kumar P, Bhat V, Salins PC. Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:e60–4.PubMedGoogle Scholar
  48. 48.
    MacDougall L, Fyfe M, Romney M, Starr M, Galanis E. Risk factors for Cryptococcus gattii infection, British Columbia. Canada Emerg Infect Dis. 2011;17:193–9.PubMedGoogle Scholar
  49. 49.
    Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291–322.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Viviani MA. Cryptococcal meningitis: diagnosis and treatment. Int J Antimicrob Agents. 1996;6:169–73.PubMedGoogle Scholar
  51. 51.
    Thomas I, Schwartz RA. Cutaneous manifestations of systemic cryptococcosis in immunosuppressed patients. J Med. 2001;32:259–66.PubMedGoogle Scholar
  52. 52.
    Negroni R. Cryptococcosis. Clin Dermatol. 2012;30:599–609.PubMedGoogle Scholar
  53. 53.
    Marques SA, Bastazini I Jr, Martins AL, Barreto JÁ, Barbieri D’Elia MP, Lastória JC, et al. Primary cutaneous cryptococcosis in Brazil: report of 11 cases in immuno competent and immunosuppressed patients. Int J Dermatol. 2012;51:780–4.PubMedGoogle Scholar
  54. 54.
    Nascimento E, Bonifácio da Silva ME, Martinez R, Von ZeskaKress MR. Primary cutaneous cryptococcosis in an immunocompetent patient due to Cryptococcus gattii molecular type VGI in Brazil: a case report and review of the literature. Mycoses. 2014;57(7):442–7.PubMedGoogle Scholar
  55. 55.
    Patel P, Ramanathan J, Kayser M, Baran JJR. Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. J Am Acad Dermatol. 2000;43:344–5.PubMedGoogle Scholar
  56. 56.
    Pau M, Lallai C, Aste N, Aste N, Atzori L. Primary cutaneous cryptococcosis in an immunocompetent host. Mycoses. 2010;53:256–8.PubMedGoogle Scholar
  57. 57.
    Iatta R, Napoli C, Borghi, Montagna MT. Rare mycosis of oral cavity: a literature epidemiological review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:647–55.PubMedGoogle Scholar
  58. 58.
    Faria PF, Vargas PA, Saldiva PH, Böhm GM, Mauad T, de Almeida OP. Tongue disease in advanced AIDS. Oral Dis. 2005;11:72–80.PubMedGoogle Scholar
  59. 59.
    Liew C, Barreto L, Mills C. Interesting case: an unusual case of oral ulceration. Br J Oral Maxillofac Surg. 2006;44:350.PubMedGoogle Scholar
  60. 60.
    Mohamad I, Abdullah B, Salim R, Rajet KA, Naik VR. Cryptococcosis: a rare fungal infection of the tongue. Southeast Asian J Trop Med Public Health. 2010;41:1188–91.PubMedGoogle Scholar
  61. 61.
    Patel S, Navas M, Batt C, Jump RLP. Oral cryptococcosis in a patient with chronic lymphocytic leukemia. Int J Infect Dis. 2016;50:18–20.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Kantarcioglu AS, Gulenc M, Yücel A, Uzun N, Taskin T, Sakiz D, Altas K. Cryptococcal parotid involvement: an uncommon localization of Cryptococcus neoformans. Med Mycol. 2006;44:279–83.PubMedGoogle Scholar
  63. 63.
    Wong DJY, Stanley P, Paddle P. Laryngeal cryptococcosis associated with inhaled corticosteroid use: case report and review of the literature. Front Surg. 2017;4:e63.Google Scholar
  64. 64.
    Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical mycology. Philadelphia: Lea & Febiger; 1992. p. 397–446.Google Scholar
  65. 65.
    Benedict K, Park BJ, Thompson GR 3rd. Coccidioidomycosis: epidemiology. Clin Epidemiol. 2013;5:185–97.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Welsh O, Vera-Cabreira L, Rendon A, Gonzalez G, Bonifaz A. Coccidioidomycosis. Clin Dermatol. 2012;30:573–91.PubMedGoogle Scholar
  67. 67.
    Kwon-Chung KJ, Bennett JE. Coccidioidomycosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical mycology. Philadelphia: Lea & Febiger; 1992. p. 357–97.Google Scholar
  68. 68.
    Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, et al. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014;20:983–90.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D, et al. Risk factor for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996. Clin Infect Dis. 2001;32:708–16.PubMedGoogle Scholar
  70. 70.
    Odio CD, Marciano BE, Galgiani JN, Holland SM. Risk factor for disseminated coccidioidomycosis, United States. Emerg Infect Dis. 2017;23:308–11.PubMedCentralGoogle Scholar
  71. 71.
    Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL, Infectious Diseases Society of America. Coccidioidomycosis. Clin Infect Dis. 2005;41(9):1217–23.PubMedGoogle Scholar
  72. 72.
    Center of Disease Control and Prevention. Increase in reported coccidioidomycosis: United States 1998–2011. MMWR Morb Mortal Wkly Rep. 2013;62:217–21.Google Scholar
  73. 73.
    Rodriguez RA, Konia T. Coccidioidomycosis of the tongue. Arch Patol Lab Med. 2005;129:e4–6.Google Scholar
  74. 74.
    Stich A, Müller A, Tintelnot K. Coccidioidomycosis with manifestation on the tongue. Pathologe. 2013;34:548–51.PubMedGoogle Scholar
  75. 75.
    Mendez LA, Florez SA, Martinez R, Almeida OP. Ulcerated lesion of the tongue as manifestation of systemic coccidioidomycosis. Case Rep Med. 2017;  https://doi.org/10.1155/2017/1489501.
  76. 76.
    Galgiani JN, Ampel NM, Blair JE. 2016 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the treatment of Coccidioidomycosis. Clin Infect Dis. 2016;61:717–22.Google Scholar
  77. 77.
    Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dernatol. 2010;35:699–705.Google Scholar
  78. 78.
    Ramos-e-Silva M. Diseases of the oral cavity caused by Protozoa. In: Lotti TM, Parish LC, Rogers IIIRS, editors. Oral diseases. Textbook and Atlas. Berlin: Springer-Verlag; 1999. p. 122–5.Google Scholar
  79. 79.
    Mignogna MD, Celentano A, Leuci S, Cascone M, Adamo D, Ruoppo E, Favia G. Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature. Oral Dis. 2015;21(1):e70–8.PubMedGoogle Scholar
  80. 80.
    García de Marcos JA, Dean Ferrer A, Alamillos Granados F, Ruiz Masera JJ, Cortés Rodríguez B, Vidal Jiménez A, et al. Localized Leishmaniasis of the oral mucosa. A report of three cases. Med Oral Patol Oral Cir Bucal. 2007;12(4):E281–6.PubMedGoogle Scholar
  81. 81.
    Da Costa DC, Palmeiro MR, Moreira JS, Martins AC, da Silva AF, Madeira Mde F, et al. Oral manifestations in the American tegumentary leishmaniasis. PLoS One. 2014;9:e109790.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Milián MA, Bagán JV, Jiménez Y, Pérez A, Scully C. Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate. Report of a case involving the palate. Oral Dis. 2002;8:59–61.PubMedGoogle Scholar
  83. 83.
    Passi D, Sharma S, Dutta, S, Gupta C. Localized leishmaniasis of oral mucosa: Report of an unusual clinicopathological entity. Hindawi Publishing Corporation. Case Reports in Dentistry. 2014;753149.  https://doi.org/10.1155/2014/753149.
  84. 84.
    Kassam K, Davidson R, Tadrous PJ, Kumar M. Lingual Leishmaniasis presenting to maxillofacial surgery in UK with successful treatment with miltefosine. Case Rep Med. 2013;2013:975131.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Daneshbod Y, Oryan A, Davarmanesh M, Shirian S, Negahban S, Aledavood A, et al. Clinical, histopathologic, and cytologic diagnosis of mucosal leishmaniasis and literature review. Arch Pathol Lab Med. 2011;135:478–82.PubMedGoogle Scholar
  86. 86.
    Almeida TF, da Silveira EM, Dos Santos CR, León JE, Mesquita AT. Exclusive primary lesion of oral leishmaniasis with Immunohistochemical diagnosis. Head Neck Pathol. 2016;10:533–7.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Crovetto-Martínez R, Aguirre-Urizar JM, Orte-Aldea C, Araluce-Iturbe I, Whyte-Orozco J, Crovetto-De la Torre MA. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(1):e20–6.PubMedGoogle Scholar
  88. 88.
    Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis. 2007;5:150–8.PubMedGoogle Scholar
  89. 89.
    Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Neto VA. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg. 2007;77:266–74.PubMedGoogle Scholar
  90. 90.
    Zerpa O, Blanco B, Kannee C, Ulrich M, Sindermann H, Engel J, Convit J. Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report. Int J Dermatol. 2006;45:751–3.PubMedGoogle Scholar
  91. 91.
    Vélez I, López L, Sánchez X, Mestra L, Rojas C, Rodriguez E. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;83:351–6.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Zerpa O, Ulrich M, Blanco B, Polegre M, Avila A, Matos N, et al. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol. 2007;156:1328–35.PubMedGoogle Scholar
  93. 93.
    Convit J, Ulrich M, Zerpa O, Borges R, Aranzazu N, Valera M, et al. Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990–99. Trans R Soc Trop Med Hyg. 2003;97(4):469–72.PubMedGoogle Scholar
  94. 94.
    Convit J, Ulrich M, Polegre MA, Avila A, Rodríguez N, Mazzedo MI, et al. Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report. Mem Inst Oswaldo Cruz. 2004;99:57–62.PubMedGoogle Scholar
  95. 95.
    Ameen M. The potential of daylight-activated photodynamic therapy for treating localized forms of cutaneous leishmaniasis in resource-limited settings. Br J Dermatol. 2015;172:1192–3.PubMedGoogle Scholar
  96. 96.
    Marks M, Solomon AW, Mabey DC. Endemic Treponemal disease. Trans R Soc Trop Med Hyg. 2014;108:601–7.PubMedPubMedCentralGoogle Scholar
  97. 97.
    Koff AB, Rosen T. Non venereal treponematoses: yaws, endemic syphilis, and pinta. J Am Acad Dermatol. 1993;29:519–35.PubMedGoogle Scholar
  98. 98.
    Antal GM, Lukehart SA, Meheus AZ. The endemic treponematoses. Microbes Infect. 2002;4:83–94.PubMedGoogle Scholar
  99. 99.
    Giacani L, Lukehart SA. The endemic treponematoses. Clin Microbiol Rev. 2014;27:89–115.PubMedPubMedCentralGoogle Scholar
  100. 100.
    Radolf JD. Treponema. In: Baron S, editor. Medical microbiology. 4th ed. Galveston: University of Texas Medical Branch at Galveston; 1996. Chapter 36.Google Scholar
  101. 101.
    Marks M, Mitjà O, Solomon AW, Asiedu KB, Mabey DC. Yaws. Br Med Bull. 2015;113:91–100.PubMedGoogle Scholar
  102. 102.
    Marks M, Lebari D, Solomon AW, Higgins SP. Yaws. Int J STD AIDS. 2015;26:696–703.PubMedGoogle Scholar
  103. 103.
    Mitjà O, Asiedu K, Mabey D. Yaws. Lancet. 2013;381:763–73.PubMedGoogle Scholar
  104. 104.
    Kazadi WM, Asiedu KB, Agana N, Mitjà O. Epidemiology of yaws: an update. Clin Epidemiol. 2014;6:119–28.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Mitjà O, Hays R, Ipai A, Penias M, Paru R, Fagaho D, et al. Single-dose azithromycin versus benzathinebenzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet. 2012;379:342–7.PubMedGoogle Scholar
  106. 106.
    Kwakye-Maclean C, Agana N, Gyapong J, Nortey P, Adu-Sarkodie Y, Aryee E, et al. A single dose oral azithromycin versus intramuscular benzathine penicillin for the treatment of yaws-a randomized non inferiority trial in Ghana. PLoS Negl Trop Dis. 2017;11(1):e0005154.PubMedPubMedCentralGoogle Scholar
  107. 107.
    Fegan D, Glennon MJ, Kool J, Taleo F. Tropical leg ulcers in children: more than yaws. Trop Dr. 2016;46:90–3.Google Scholar
  108. 108.
    Rivera-Olivero IA, Guevara A, Escalona A, Oliver M, Pérez-Alfonzo R, Piquero J, et al. Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty. Enferm Infecc Microbiol Clin. 2006;24:302–6.PubMedGoogle Scholar
  109. 109.
    Torres-Coy JA, Rodríguez-Castillo BA, Pérez-Alfonzo R, DE Waard JH. Source investigation of two outbreaks of skin and soft tissue infection by Mycobacterium abscessus subsp. abscessus in Venezuela. Epidemiol Infect. 2016;144:1117–20.PubMedGoogle Scholar
  110. 110.
    Peralta G, Tobin-D’Angelo M, Parham A, Edison L, Lorentzson L, Smith C, et al. Notes from the field: Mycobacterium abscessus infections among patients of a pediatric dentistry practice – Georgia, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:355–6.PubMedGoogle Scholar
  111. 111.
    Lange CG, Woolley IJ, Brodt RH. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? Drugs. 2004;64:679–92.PubMedGoogle Scholar
  112. 112.
    Safraneck TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA. Myobacterirum chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 1987;317:197–201.Google Scholar
  113. 113.
    Murillo J, Torres J, Bofill L, Ríos-Fabra A, Irausquin E, Istúriz R, et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol. 2000;136:1347–52.PubMedGoogle Scholar
  114. 114.
    Robinson P, Farthing P, Scott GM, Bennett JH. Oral Mycobacterium avium complex infection in a patient with HIV-related disease. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:177–9.PubMedGoogle Scholar
  115. 115.
    Alagarswamy RK, Halfpenny W, Thiruchelvam JK, Mohamid W. Rare presentation of Mycobacterium avium-intracellulare infection. Br J Oral Maxillofac Surg. 2007;45:670–2.PubMedGoogle Scholar
  116. 116.
    Cox HJ, Brightwell AP, Riordan T. Non-tuberculous mycobacterial infections presenting as salivary gland masses in children: investigation and conservative management. J Laryngol Otol. 1995;109:525–30.PubMedGoogle Scholar
  117. 117.
    Berkovic J, Vanchiere JA, Gungor A. Non tuberculous mycobacterial lesion of the parotid gland and facial skin in a 4 year old girl: a proposed treatment strategy. Am J Otolaryngol. 2016;37:89–94.PubMedGoogle Scholar
  118. 118.
    Bonali M, Mattioli F, Alicandri-Ciufelli M, Presutti L. Atypical mycobacteriosis involving parotid and para-retropharyngeal spaces. Eur Arch Otorhinolaryngol. 2016;273:4031–3.PubMedGoogle Scholar
  119. 119.
    Yamanaka T, Okamoto H, Hosoi H. Non-tuberculous mycobacterial infection of the parotid gland in an immunocompetent elderly patient. BMJ Case Rep. 2013;16:2013.Google Scholar
  120. 120.
    Motswaledi MH, Khammissa RA, Jadwat Y, Lemmer J, Feller L. Oral sarcoidosis: a case report and review of the literature. Aust Dent J. 2014;59:389–94.PubMedGoogle Scholar
  121. 121.
    Sharma P, Saxena S, Aggarwal P, Reddy V. Tuberculosis of odontogenic cyst. Indian J Tuberc. 2013;60:50–4.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ricardo Pérez-Alfonzo
    • 1
  • Silvio Alencar-Marques
    • 2
  • Elda Giansante
    • 3
  • Antonio Guzmán-Fawcett
    • 4
  1. 1.Dermatologic Program, “Jacinto Convit” Institute of BiomedicineCentral University of VenezuelaCaracasVenezuela
  2. 2.Department of Dermatology and RadiotherapyBotucatu School of Medicine – São Paulo State University (UNESP)BotucatuBrazil
  3. 3.University Hospital Caracas, Central University of VenezuelaCaracasVenezuela
  4. 4.Pierre Fauchard Faculty of DentistryAutonomous University of ParaguayAsunciónParaguay

Personalised recommendations